Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
10,001 - 25,000 - Monthly Reach
Unique listeners across all episodes (30 days)
25,001 - 75,000 - Active Followers
Loyal subscribers who consistently listen
5,001 - 15,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
How Technology Partner Programs Drive CRO Competitive Advantage—and Patient Impact
Apr 16, 2026
35m 12s
Beyond the Lab: Policy, Politics, and the Future of Research
Mar 24, 2026
30m 07s
Maximizing Trial Value in Resource-Constrained Biotechs
Mar 12, 2026
26m 45s
Translating Good Ideas into Products
Mar 2, 2026
26m 46s
Simulating Success: Elevating Clinical Trial Training
Feb 12, 2026
25m 29s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 4/16/26 |  How Technology Partner Programs Drive CRO Competitive Advantage—and Patient Impact | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, interviews Mitchell Bayer, Managing Principal of Arlen Consulting Group, about the evolution of the life science industry and the role of CROs. Mitch discusses his 24-year career, starting at Medidata, where he spearheaded the ASPire to Win™ CRO partner program, which grew to 16 partners by 2009. He emphasizes the importance of integrating technology with CROs to enhance competi... | 35m 12s | ||||||
| 3/24/26 |  Beyond the Lab: Policy, Politics, and the Future of Research | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, interviews Nicholas Dirks, President and CEO of The New York Academy of Sciences. Nick emphasizes the importance of federal funding for basic research and the need for international collaboration while highlighting the impact of the pandemic and the current administration on scientific research, funding cuts, and the exodus of international researchers. He also explains why the ... | 30m 07s | ||||||
| 3/12/26 |  Maximizing Trial Value in Resource-Constrained Biotechs | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, speaks with Nathalie Riebel, CEO and founder of Oncospire Consultants, a consultancy specializing in small biotechs. Nathalie points to the $80 billion pharma outsourcing market and the performance and quality challenges that accompany it. The data consistently shows that this massive transfer of work is plagued by delays, quality failures, sponsor dissatisfaction, and governance gaps... | 26m 45s | ||||||
| 3/2/26 |  Translating Good Ideas into Products | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, speaks with Dr. Peter Reinhart, Ph.D., Director of the Institute for Applied Life Sciences (IALS) at UMass Amherst. Dr. Reinhart shares his journey from academia to founding startups, including developing therapeutics for Alzheimer's and Parkinson's. IALS, funded by a $95 million award from the Massachusetts Life Science Center, provides translational research facilities and sup... | 26m 46s | ||||||
| 2/12/26 |  Simulating Success: Elevating Clinical Trial Training | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, and Jenna Rouse, Global Head of Clinical Operations at Simulations Plus discuss the benefits of simulation-based clinical research training, which allows sites to practice protocol-specific tasks without risking patient safety. Jenna shares a case study where simulation training improved procedural accuracy from 14% to 86% over six months. The discussion emphasizes the importanc... | 25m 29s | ||||||
| 1/27/26 |  Incubators. The Inside Story. | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, speaks with Ezekiel Kelley, VP of Engagement and Growth at the Frederick Innovation and Technology Center (FITCI), about the importance of incubators in driving innovation. FITCI, a business incubator in Frederick, Maryland, supports life science startups by providing resources, office and lab space, and connections to state and federal resources. FITCI has grown from 40 to near... | 21m 46s | ||||||
| 1/7/26 |  Building a Professional Services Firm | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, and Jeremy Bromberg, an independent operations advisor with a background in life sciences and pharmaceutical market research, share insights on improving business operations. The conversation highlights the importance of compliance, effective pricing strategies, and organizational structure. Jeremy stresses the need for specialized knowledge in life sciences, the significance of... | 25m 08s | ||||||
| 12/19/25 |  Beyond Compliance: Building Brands in Regulated Markets | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, and Roy Strunin, Director of Marketing at BrandUp Strategy, discuss the intersection of business, science, and marketing in the pharmaceutical, biotech, and medical device industries. Keith highlights the collaboration between Court Square Group, a managed service firm specializing in IT infrastructure for life science organizations, and BrandUp Strategy, a full-service marketing agen... | 26m 46s | ||||||
| 11/18/25 |  Translational Science in Action. Driving Innovation. | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, interviews Joseph Jerry, Ph.D., a researcher at UMass Amherst and Science Director of Pioneer Valley Life Sciences Institute (PVLSI). Dr. Jerry explains PVLSI's role in translational research, particularly in breast cancer, and the creation of the breast research registry and HistoSpring. They discuss the importance of diverse patient populations, the use of human tissues for research... | 28m 59s | ||||||
| 11/5/25 |  Effectively Selling Science. Overcoming Barriers to Growth. | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, and Dave Kwajewski, Executive Director of Business Development at Corealis Pharma, discuss the challenges and strategies in selling science. Dave, with 22.5 years in sales, emphasizes the importance of understanding scientific processes and the evolution of sales techniques, from traditional trade shows to AI-driven interactions. He highlights the need for companies to focus on ... | 28m 21s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/23/25 |  AI in Clinical Trials. A Scientist's Perspective. | Keith Parent, CEO of Court Square Group, discusses the intersection of science and business in drug development with Dr. Joseph Geraci, Founder, Chief Scientific and Technical Officer of NetraMark. Dr. Geraci, with a background in mathematics and AI, focuses on understanding patient populations and improving clinical trials. He explains how NetraMark's AI technology can analyze small, complex data sets to identify treatment and placebo responder subpopulations and improve drug efficacy. Dr. G... | 25m 57s | ||||||
| 10/9/25 |  Pharma Start-ups. Perspectives from a Serial Entrepreneur. | In this episode of the Driving the Business of Science podcast, hosted by Keith Parent, CEO of Court Square Group, guest Mark Connell, Co-Founder and President of SLBST Pharma, discusses the company’s mission to repurpose hydroxychloroquine to treat endometriosis, a condition affecting 7 million American women. Despite limited current therapies, SLBST Pharma aims to leverage the drug’s proven efficacy in reducing lesions by 60%. Challenges include navigating the complexities of drug developme... | 29m 05s | ||||||
| 9/26/25 |  Establishing Worldwide Networks for Pharmaceutical Companies | In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, and guest Michael Joseph, CEO of Technium, discuss their collaboration on global networks for the life science industry. Technium specializes in connecting data from the edge to the cloud, offering secure network services and leveraging AI advancements. Their recent projects include assisting Moderna with their global network during the COVID pandemic and designing a network for Front... | 27m 28s | ||||||
| 9/11/25 |  From Small Introductions to Global Projects: A Networking Approach to Life Sciences Partnerships | Keith Parent, CEO of Court Square Group, discusses the complexities of the life science industry and introduces Chris Matheus from the Global Life Science Alliance (GLSA). Chris, with 30 years in clinical research, co-founded GLSA to connect smaller companies with business development opportunities and experts. The conversation emphasizes the importance of collaboration and networking, highlighting GLSA's role in facilitating connections for regulatory consulting, pre-clinical, and clinical t... | 21m 36s | ||||||
| 8/25/25 |  The Evolving World of Data Management in Life Science | In this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, discusses with Mario Perkins, President of Triam Ltd, the intersection of IT infrastructure and data management in the life sciences. Triam specializes in data management and analytics, particularly in healthcare and life sciences, and has recently partnered with Court Square. They discuss the shift from legacy systems like SAS to open-source tools like Python and R, disruptive technologie... | 28m 25s | ||||||
| 8/13/25 |  Making Connections Internationally. How Does it Work? | In this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, interviews Christa Bleyleben, Managing Partner at MassGlobal Partners. Christa's firm helps international early and growth-stage companies navigate the U.S. market, providing programs for C-level executives to learn business practices, networking, and cultural differences. They work with companies from various sectors, including life sciences, robotics, and AI, and have supported firms fro... | 27m 47s | ||||||
| 7/25/25 |  Engaging with Key Opinion Leaders (KOLs) | In this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, speaks with Arielle Smith, President of Life Sciences at Event Cadence about their event technology platform which supports medical conferences and Key Opinion Leader (KOL) engagement. They discuss the importance of in-person interactions and the evolving landscape of HCP (Healthcare Provider) engagement. Event Cadence's Ensemble software facilitates omni-channel engagement, adapting to di... | 26m 10s | ||||||
| 7/18/25 |  Unlocking Value: Why Latin America is the Strategic Choice for Phase 1 Trials | In this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, interviews Sara Tylosky, CEO of Farmacon Global, about the Latin American market for clinical trials. Farmacon Global, a strategic partner with a network of physicians, focuses on rare diseases, oncology, and immunology in Latin America. Sara highlights the region's diversity, cost savings, and fast recruitment, noting that Latin America represents 0.7% of global phase 1 studies but has a ... | 23m 29s | ||||||
| 7/1/25 |  Mental Health Across the Life Science Spectrum | In this episode of the Driving the Business of Science podcast, Keith Parent, CEO of Court Square Group, hosts Samantha Trotman Burman to discuss mental health across the life science spectrum. Samantha, CEO and co-founder of StoryCatch Partners, shares her journey in mental health advocacy, driven by personal experiences and the need for better support and data collection. She emphasizes the importance of integrating mental and physical health data, using real-world examples like knee replac... | 25m 08s | ||||||
| 6/17/25 |  Pharmacovigilance Compliance for Small and Mid-sized Sponsors | In this episode of Driving the Business of Science, Keith Parent, CEO of Court Square Group discusses pharmacovigilance compliance for small and mid-sized sponsors with Betty Cory, President of Regxia. Betty explains that pharmacovigilance monitors drug safety in real-world use, often revealing unforeseen adverse effects. Small companies struggle with managing vast amounts of data, necessitating electronic systems. Betty emphasizes the importance of finding partners who understand small busin... | 20m 50s | ||||||
| 6/4/25 |  Challenges and Opportunities in AI Implementation | In this episode of Driving the Business of Science, Keith Parent, CEO of Court Square Group, talks with Catherine Lunardi, CEO of GENAIZ, about the challenges and opportunities of implementing Artificial Intelligence (AI) in life science companies. Catherine explains her company's Intelligent Automation solutions, particularly their data orchestration platform. They discuss their partnership, which began at an economic development forum in Massachusetts. Catherine shares her background in pha... | 25m 58s | ||||||
| 5/19/25 |  De-Risking the Early Phase Clinical Trial Supply Chain | Keith Parent, CEO of Court Square Group, discusses De-Risking the Early Phase Clinical Trial Supply Chain with Jim Kernan, CEO of PRONAV Clinical, a 40-year veteran of the pharmaceutical industry. Their conversation focuses on early-phase clinical supply chains, highlighting the shift from linear to multi-nodal supply chains in biotech. Jim explains the role of the Qualified Person (QP) in ensuring GMP compliance and data management, emphasizing the importance of secure data handling. They al... | 26m 36s | ||||||
| 5/6/25 |  Elevating Life Science Meetings & Events | In this episode of Driving the Business of Science, Elevating Life Science Meetings & Events, Keith Parent, CEO of Court Square Group, discusses with Sam Ali, co-founder of Precision Evolution Global, the importance of attending and participating in industry events. Effective industry events aimed at decision-makers in pharma, biotech, and CROs, covering clinical trials, drug discovery, and pharma supply chains, connect key stakeholders who might otherwise struggle to find each other. As ... | 24m 32s | ||||||
| 4/22/25 |  The Importance of Quality | Keith Parent, CEO of Court Square Group, discusses the business aspects of drug development with James Blackwell, Ph.D., MBA, President of Windshire Group. They explore the importance of quality in life science, emphasizing the need for a holistic approach beyond compliance. Blackwell highlights the significance of modality-agnostic strategies, the impact of AI on efficiency, and the necessity of a simple yet effective quality system. He shares insights on managing compliance, the importance ... | 27m 47s | ||||||
| 4/7/25 |  Stakeholder Engagement: CROs, Vendors, and Sites | In this episode of Driving the Business of Science, Stakeholder Engagement: CROs, Vendors, and Sites, Keith Parent, CEO of Court Square Group, discusses the complexities of stakeholder engagement in the life science industry with Kimberly Guedes, VP of Clinical Operations at Intensity Pharmaceuticals. Keith and Kim explore the challenges facing small biotechs when partnering with large CROs, emphasizing the need for fit for purpose, cost-effective solutions like RegDocs365™. Kim discusses the... | 26m 30s | ||||||
Showing 25 of 29
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.